{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:31Z","timestamp":1792788091843,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Shen Kang Hospital Development Center New Frontier Technology Joint Project of municipal hospital","award":["SHDC12017114"],"award-info":[{"award-number":["SHDC12017114"]}]},{"name":"Shanghai Shen Kang Hospital Development Center New Frontier Technology Joint Project of municipal hospital","award":["SHDC12017114"],"award-info":[{"award-number":["SHDC12017114"]}]},{"name":"Shanghai Shen Kang Hospital Development Center New Frontier Technology Joint Project of municipal hospital","award":["SHDC12017114"],"award-info":[{"award-number":["SHDC12017114"]}]},{"name":"Shanghai Shen Kang Hospital Development Center New Frontier Technology Joint Project of municipal hospital","award":["SHDC12017114"],"award-info":[{"award-number":["SHDC12017114"]}]},{"name":"Shanghai Science and Technology Development Funds","award":["15411950103"],"award-info":[{"award-number":["15411950103"]}]},{"name":"Shanghai Science and Technology Development Funds","award":["15411950103"],"award-info":[{"award-number":["15411950103"]}]},{"name":"Shanghai Science and Technology Development Funds","award":["18ZR1436300"],"award-info":[{"award-number":["18ZR1436300"]}]},{"name":"Shanghai Science and Technology Development Funds","award":["14411965800"],"award-info":[{"award-number":["14411965800"]}]},{"name":"Shanghai Pudong New Area Science and Technology Development Fund for the People's Livelihood Research Project","award":["PKJ2017-Y52"],"award-info":[{"award-number":["PKJ2017-Y52"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13014-019-1216-1","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T08:03:31Z","timestamp":1548403411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy"],"prefix":"10.1186","volume":"14","author":[{"given":"Jian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiade J.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"1216_CR1","doi-asserted-by":"publisher","unstructured":"Mirimanoff R-O. Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung? Chin Clin Oncol. 2015;4(42). \n                    https:\/\/doi.org\/10.3978\/j.issn.2304-3865.2015.11.02\n                    \n                  .","DOI":"10.3978\/j.issn.2304-3865.2015.11.02"},{"key":"1216_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijrobp.2016.01.036","volume":"95","author":"JY Chang","year":"2016","unstructured":"Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB, Rengan R, et al. Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2016;95:505\u201316.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ijrobp.2009.04.023","volume":"75","author":"OK Macdonald","year":"2009","unstructured":"Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, et al. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int J Radiat Oncol Biol Phys. 2009;75:950\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.023\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ijrobp.2010.03.012","volume":"80","author":"SP Register","year":"2011","unstructured":"Register SP, Zhang X, Mohan R, Chang JY. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;80:1015\u201322. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2010.03.012\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ijrobp.2014.07.045","volume":"90","author":"JY Chang","year":"2014","unstructured":"Chang JY, Li H, Zhu XR, Liao Z, Zhao L, Liu A, et al. Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2014;90:809\u201318. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.045\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR6","volume-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae)","author":"DS Ettinger","year":"2017","unstructured":"Ettinger DS, et al. Non-small cell lung cancer. In: NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae); 2017. \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx#nscl\n                    \n                  . Accessed 15 Oct 2017."},{"key":"1216_CR7","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ijrobp.2010.04.049","volume":"80","author":"JY Chang","year":"2011","unstructured":"Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, et al. Toxicity and patterns of failure of adaptive\/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;80:1350\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.049\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR8","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ijrobp.2014.01.022","volume":"88","author":"JY Chang","year":"2014","unstructured":"Chang JY, Li Q-Q, Xu Q-Y, Allen PK, Rebueno N, Gomez DR, et al. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a \u201cno fly zone\u201d. Int J Radiat Oncol Biol Phys. 2014;88:1120\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2014.01.022\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/0284186X.2013.769063","volume":"52","author":"RJ Colaco","year":"2013","unstructured":"Colaco RJ, Huh S, Nichols RC, Morris CG, D'Agostino H, Flampouri S, et al. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Acta Oncol. 2013;52:506\u201313. \n                    https:\/\/doi.org\/10.3109\/0284186X.2013.769063\n                    \n                  .","journal-title":"Acta Oncol"},{"key":"1216_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ijrobp.2013.03.035","volume":"86","author":"DR Gomez","year":"2013","unstructured":"Gomez DR, Gillin M, Liao Z, Wei C, Lin SH, Swanick C, et al. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;86:665\u201370. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2013.03.035\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","volume":"99","author":"JY Chang","year":"2017","unstructured":"Chang JY, Zhang X, Knopf A, Li H, Mori S, Dong L, et al. Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee. Int J Radiat Oncol Biol Phys. 2017;99:41\u201350. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.014\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.radonc.2014.11.020","volume":"113","author":"D Richter","year":"2014","unstructured":"Richter D, Graeff C, J\u00e4kel O, Combs SE, Durante M, Bert C. Residual motion mitigation in scanned carbon ion beam therapy of liver tumors using enlarged pencil beam overlap. Radiother Oncol. 2014;113:290\u20135. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2014.11.020\n                    \n                  .","journal-title":"Radiother Oncol"},{"key":"1216_CR13","unstructured":"Andrea B. et al. Stereotactic Body Radiation Therapy in Treating Patients with Stage I Non-Small Cell Lung Cancer. \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00750269?term=RTOG+0813&rank=1\n                    \n                  . Accessed 3 Sept 2018."},{"key":"1216_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/thorax.56.8.628","volume":"56","author":"NP Rowell","year":"2001","unstructured":"Rowell NP, Williams CJ. Radical radiotherapy for stage I\/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax. 2001;56:628\u201338.","journal-title":"Thorax"},{"key":"1216_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/JTO.0000000000000524","volume":"10","author":"G Boily","year":"2015","unstructured":"Boily G, Filion \u00c9, Rakovich G, Kopek N, Tremblay L, Samson B, et al. Stereotactic ablative radiation therapy for the treatment of early-stage non-small-cell lung cancer: CEPO review and recommendations. J Thorac Oncol. 2015;10:872\u201382. \n                    https:\/\/doi.org\/10.1097\/JTO.0000000000000524\n                    \n                  .","journal-title":"J Thorac Oncol"},{"key":"1216_CR16","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1002\/cncr.30693","volume":"123","author":"B Sun","year":"2017","unstructured":"Sun B, Brooks E, Komaki RU, Liao Z, Jeter MD, McAleer MF, et al. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: results of a phase 2 clinical trial. Cancer. 2017;123:3031\u20139. \n                    https:\/\/doi.org\/10.1002\/cncr.30693\n                    \n                  .","journal-title":"Cancer"},{"key":"1216_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jjco\/hyy034","volume":"48","author":"Y Nagata","year":"2018","unstructured":"Nagata Y, Kimura T. Stereotactic body radiotherapy (SBRT) for stage I lung cancer. Jpn J Clin Oncol. 2018;48:405\u20139. \n                    https:\/\/doi.org\/10.1093\/jjco\/hyy034\n                    \n                  .","journal-title":"Jpn J Clin Oncol"},{"key":"1216_CR18","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMc1203770","volume":"366","author":"MN Corradetti","year":"2012","unstructured":"Corradetti MN, Haas AR, Rengan R. Central-airway necrosis after stereotactic body-radiation therapy. N Engl J Med. 2012;366:2327\u20139. \n                    https:\/\/doi.org\/10.1056\/NEJMc1203770\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1216_CR19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","volume":"11","author":"H Tekatli","year":"2016","unstructured":"Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, Bongers E, et al. Outcomes of Hypofractionated high-dose radiotherapy in poor-risk patients with \u201cUltracentral\u201d non-small cell lung cancer. J Thorac Oncol. 2016;11:1081\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jtho.2016.03.008\n                    \n                  .","journal-title":"J Thorac Oncol"},{"key":"1216_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.radonc.2010.09.006","volume":"97","author":"BS Hoppe","year":"2010","unstructured":"Hoppe BS, Huh S, Flampouri S, Nichols RC, Oliver KR, Morris CG, et al. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. Radiother Oncol. 2010;97:425\u201330. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2010.09.006\n                    \n                  .","journal-title":"Radiother Oncol"},{"key":"1216_CR21","first-page":"5099","volume":"34","author":"T Ebara","year":"2014","unstructured":"Ebara T, Shimada H, Kawamura H, Shirai K, Saito J-I, Kawashima M, et al. Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer. Anticancer Res. 2014;34:5099\u2013104.","journal-title":"Anticancer Res"},{"key":"1216_CR22","doi-asserted-by":"publisher","first-page":"e0175589","DOI":"10.1371\/journal.pone.0175589","volume":"12","author":"K Shirai","year":"2017","unstructured":"Shirai K, Kawashima M, Saitoh J-I, Abe T, Fukata K, Shigeta Y, et al. Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-a pilot study. Amendola R, editor. Public Library of Science. PLoS ONE. 2017;12:e0175589. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0175589\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"1216_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijrobp.2005.10.031","volume":"65","author":"K Nihei","year":"2006","unstructured":"Nihei K, Ogino T, Ishikura S, Nishimura H. High-dose proton beam therapy for stage I non-small-cell lung cancer. Radiat Oncol Biol. 2006;65:107\u201311. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2005.10.031\n                    \n                  .","journal-title":"Radiat Oncol Biol"},{"key":"1216_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ijrobp.2006.12.063","volume":"68","author":"M Hata","year":"2007","unstructured":"Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I\/II clinical study. Radiat Oncol Biol. 2007;68:786\u201393. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2006.12.063\n                    \n                  .","journal-title":"Radiat Oncol Biol"},{"key":"1216_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ijrobp.2009.07.1707","volume":"78","author":"H Nakayama","year":"2010","unstructured":"Nakayama H, Sugahara S, Tokita M, Satoh H, Tsuboi K, Ishikawa S, et al. Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of Tsukuba. Int J Radiat Oncol Biol Phys. 2010;78:467\u201371. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1707\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/JTO.0b013e3181560a68","volume":"2","author":"T Miyamoto","year":"2007","unstructured":"Miyamoto T, Baba M, Sugane T, Nakajima M, Yashiro T, Kagei K, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol. 2007;2:916\u201326. \n                    https:\/\/doi.org\/10.1097\/JTO.0b013e3181560a68\n                    \n                  .","journal-title":"J Thorac Oncol"},{"key":"1216_CR27","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ijrobp.2006.10.006","volume":"67","author":"T Miyamoto","year":"2007","unstructured":"Miyamoto T, Baba M, Yamamoto N, Koto M, Sugawara T, Yashiro T, et al. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys. 2007;67:750\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2006.10.006\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1216_CR28","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/cncr.24998","volume":"116","author":"H Iwata","year":"2010","unstructured":"Iwata H, Murakami M, Demizu Y, Miyawaki D, Terashima K, Niwa Y, et al. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer. Cancer. Wiley Subscription Services, Inc, A Wiley Company. 2010;116:2476\u201385. \n                    https:\/\/doi.org\/10.1002\/cncr.24998\n                    \n                  .","journal-title":"Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1216-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1216-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1216-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T19:11:48Z","timestamp":1579893108000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1216-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1216-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the institutional review board and written informed consents from all patients were obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"16"}}